Search Medical Condition
Please enter condition
Please choose location from dropdown

Niederdorfelden, Germany Clinical Trials

A listing of Niederdorfelden, Germany clinical trials actively recruiting patients volunteers.

RESULTS

Found (435) clinical trials

Prospan Hustenz pfchen - Investigation on Efficacy and Tolerability in Children

After interim analysis of the first part the clinical study will be continued as follows: Double blind, placebo controlled, randomised, multi-centre study with 2-parallel groups for the treatment of acute bronchitis accompanied by coughing in children aged 0 - 6 years to demonstrate efficacy and safety of Prospan® Hustenzäpfchen. For ...

Phase

0.0 miles

Learn More »

AMPLATZER LAA Occluder Post Approval Study (PAS)

The AMPLATZER LAA Occluder device will be clinically evaluated through this post approval study. This is a non-randomized multicenter study on patients who have undergone a procedure to implant an AMPLATZER LAA Occluder or will undergo an implant of an AMPLATZER LAA Occluder.

Phase N/A

4.48 miles

Learn More »

Non-interventional Study of Kyprolis in Combination With Revlimid and Dexamethasone or Dexamethasone Alone in Multiple Myeloma Patients

The dual combination of lenalidomide (Revlimid) (R) and dexamethasone (d) (Rd) is a standard regimen to treat MM patients who have received at least one prior therapy. Recently published clinical data indicate that the next-generation proteasome inhibitor carfilzomib (Kyprolis) (K) may substantially change the treatment paradigm for patients with relapsed ...

Phase N/A

4.48 miles

Learn More »

Long Term Efficacy and Safety of Inhaled Colistimethate Sodium in Bronchiectasis Subjects With Chronic Pseudomonas Aeruginosa Infection.

The co-primary objectives of the trial are to investigate the effect of the use of inhaled colistimethate sodium, administered twice daily via the I-neb for 24 months, compared to placebo in subjects with non-cystic fibrosis bronchiectasis (NCFB) chronically infected with P. aeruginosa on: the frequency of pulmonary exacerbations; the number ...

Phase

4.48 miles

Learn More »

Cryo AF Global Registry

The Cryo AF Global Registry is a prospective, global, multi-center, observational post-market registry (PMR). The purpose of this study is to evaluate and describe clinical performance and safety data in a broad patient population treated with a commercially available Arctic Front Family of Cardiac Cryoablation Catheters (hereafter referred to as ...

Phase N/A

4.48 miles

Learn More »

Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.

The purpose of the study is to determine the effect of LCZ696 vs. Enalapril on improvement of excercise capacity in patients with chronic heart failure with reduced ejection fraction

Phase

4.48 miles

Learn More »

Study to Evaluate the Use of RenalGuard to Protect Patients at High Risk of AKI

The Strength Trial is a randomized, international (France and Germany) and multicentre (7) trial. The patients population targeted is suffering from kidney insufficiency (estimated Glomerular Filtration Rate (eGFR) between 15 to 40 ml/min/m2) need to go through a complex cardiovascular intervention.. This is a population of patients at high risk ...

Phase N/A

4.48 miles

Learn More »

Controlling and Lowering Blood Pressure With the MobiusHD

The CALM-DIEM Trial is an open-label, prospective, multicenter study for patients who have been selected for treatment with the MobiusHD.

Phase N/A

4.48 miles

Learn More »

Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)

A prospective, single-arm, multi-center study, enrolling symptomatic patients with chronic functional tricuspid regurgitation. The study will include up to 60 subjects from up to 15 sites in Europe and the United States. Follow-up evaluations will be conducted through 5 years post implantation.

Phase N/A

4.48 miles

Learn More »

ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer

This is an international, multi-center, open-label, randomized, Phase III study in patients with metastatic TNBC refractory or relapsing after at least 2 prior chemotherapies (including a taxane) for their metastatic disease. The primary objective of this study is to compare the efficacy of sacituzumab govitecan to the treatment of physician's ...

Phase

4.48 miles

Learn More »